Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

744 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cardiotoxicity and myocardial hypoperfusion associated with anti-vascular endothelial growth factor therapies: prospective cardiac magnetic resonance imaging in patients with cancer.
Dobbin SJH, Mangion K, Berry C, Roditi G, Basak S, Sourbron S, White J, Venugopal B, Touyz RM, Jones RJ, Petrie MC, Lang NN. Dobbin SJH, et al. Among authors: jones rj. Eur J Heart Fail. 2020 Jul;22(7):1276-1277. doi: 10.1002/ejhf.1847. Epub 2020 May 7. Eur J Heart Fail. 2020. PMID: 32379945 Free article. No abstract available.
A monolithic single-chip point-of-care platform for metabolomic prostate cancer detection.
Annese VF, Patil SB, Hu C, Giagkoulovits C, Al-Rawhani MA, Grant J, Macleod M, Clayton DJ, Heaney LM, Daly R, Accarino C, Shah YD, Cheah BC, Beeley J, Evans TRJ, Jones R, Barrett MP, Cumming DRS. Annese VF, et al. Microsyst Nanoeng. 2021 Mar 5;7:21. doi: 10.1038/s41378-021-00243-4. eCollection 2021. Microsyst Nanoeng. 2021. PMID: 34567735 Free PMC article.
Immune checkpoint inhibitors in renal cell carcinoma.
Ross K, Jones RJ. Ross K, et al. Among authors: jones rj. Clin Sci (Lond). 2017 Oct 27;131(21):2627-2642. doi: 10.1042/CS20160894. Print 2017 Nov 1. Clin Sci (Lond). 2017. PMID: 29079639 Free PMC article. Review.
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.
Brown JE, Royle KL, Gregory W, Ralph C, Maraveyas A, Din O, Eisen T, Nathan P, Powles T, Griffiths R, Jones R, Vasudev N, Wheater M, Hamid A, Waddell T, McMenemin R, Patel P, Larkin J, Faust G, Martin A, Swain J, Bestall J, McCabe C, Meads D, Goh V, Min Wah T, Brown J, Hewison J, Selby P, Collinson F; STAR Investigators. Brown JE, et al. Lancet Oncol. 2023 Mar;24(3):213-227. doi: 10.1016/S1470-2045(22)00793-8. Epub 2023 Feb 13. Lancet Oncol. 2023. PMID: 36796394 Free article. Clinical Trial.
Pediatric and young adult renal cell carcinoma.
Ray S, Jones R, Pritchard-Jones K, Dzhuma K, van den Heuvel-Eibrink M, Tytgat G, van der Beek J, Oades G, Murphy D. Ray S, et al. Pediatr Blood Cancer. 2020 Nov;67(11):e28675. doi: 10.1002/pbc.28675. Epub 2020 Sep 1. Pediatr Blood Cancer. 2020. PMID: 32869954 Review.
744 results